(UL) Unilever - Overview
Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 123.971m USD | Total Return: -19.6% in 12m
Avg Turnover: 219M
Warnings
Choppy
Tailwinds
No distinct edge detected
Unilever PLC is a London-based multinational corporation specializing in fast-moving consumer goods (FMCG). The company manages a diverse portfolio across four primary segments: Beauty & Wellbeing, Personal Care, Home Care, and Foods. Its brand stable includes globally recognized names such as Dove, Knorr, Hellmann’s, and Rexona, serving markets across the Americas, Europe, Asia Pacific, and Africa.
The FMCG sector is characterized by high volume, low-margin products that require extensive distribution networks and significant marketing investment to maintain market share. Unilever utilizes a multi-channel business model, selling through traditional retail, e-commerce, and professional food services to mitigate regional economic volatility. For a deeper analysis of these market dynamics, you may wish to explore the data on ValueRay.
Founded in 1860, the company has expanded its reach into high-growth categories like Prestige Beauty and Health & Wellbeing. This strategic diversification allows the firm to balance stable revenue from household staples with the higher margins typically found in premium skincare and nutritional supplements.
- Rising input costs and commodity inflation pressure underlying operating margins
- Strategic divestment of ice cream unit streamlines portfolio for higher growth
- Emerging market volume growth offsets sluggish consumer demand in European markets
- Prestige beauty and health segments drive premiumization and revenue expansion
- Brand marketing reinvestment levels determine long-term market share retention rates
| Net Income: 11.8b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 5.18 > 1.0 |
| NWC/Revenue: -4.13% < 20% (prev -6.27%; Δ 2.14% < -1%) |
| CFO/TA 0.26 > 3% & CFO 18.0b > Net Income 11.8b |
| Net Debt (27.0b) to EBITDA (24.1b): 1.12 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.20b) vs 12m ago -13.16% < -2% |
| Gross Margin: 75.92% > 18% (prev 62.65%; Δ 13.27% > 0.5%) |
| Asset Turnover: 152.8% > 50% (prev 118.9%; Δ 33.91% > 0%) |
| Interest Coverage Ratio: 14.04 > 6 (EBIT TTM 21.1b / Interest Expense TTM 1.50b) |
| A: -0.07 (Total Current Assets 17.1b - Total Current Liabilities 21.7b) / Total Assets 70.4b |
| B: 0.63 (Retained Earnings 44.2b / Total Assets 70.4b) |
| C: 0.29 (EBIT TTM 21.1b / Avg Total Assets 72.8b) |
| D: 0.29 (Book Value of Equity 15.5b / Total Liabilities 52.9b) |
| Altman-Z'' = 3.87 = AA |
| DSRI: 1.25 (Receivables 7.67b/4.94b, Revenue 111b/89.4b) |
| GMI: 0.83 (GM 62.65% / 75.92%) |
| AQI: 1.02 (AQ_t 0.63 / AQ_t-1 0.62) |
| SGI: 1.24 (Revenue 111b / 89.4b) |
| TATA: -0.09 (NI 11.8b - CFO 18.0b) / TA 70.4b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of June 03, 2026, the stock is trading at USD 55.53 with a total of 5,106,387 shares traded.
Over the past week, the price has changed by -2.70%,
over one month by -4.51%,
over three months by -21.57% and
over the past year by -19.59%.
Unilever has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy UL.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 68 | 22.4% |
Market Cap EUR = 106b (124b USD * 0.859 USD.EUR)
P/E Trailing = 18.9601
P/E Forward = 15.873
P/S = 2.4547
P/B = 6.901
P/EG = 10.5758
Revenue TTM = 111b EUR
EBIT TTM = 21.1b EUR
EBITDA TTM = 24.1b EUR
Long Term Debt = 25.7b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.58b EUR (from shortTermDebt, last quarter)
Debt = 30.9b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 27.0b EUR (calculated: Debt 30.9b - CCE 3.94b)
Enterprise Value = 133b EUR (106b + Debt 30.9b - CCE 3.94b)
Interest Coverage Ratio = 14.04 (Ebit TTM 21.1b / Interest Expense TTM 1.50b)
EV/FCF = 8.99x (Enterprise Value 133b / FCF TTM 14.8b)
FCF Yield = 11.12% (FCF TTM 14.8b / Enterprise Value 133b)
FCF Margin = 13.34% (FCF TTM 14.8b / Revenue TTM 111b)
Net Margin = 10.62% (Net Income TTM 11.8b / Revenue TTM 111b)
Gross Margin = 75.92% ((Revenue TTM 111b - Cost of Revenue TTM 26.8b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.89 (Enterprise Value 133b / Total Assets 70.4b)
Interest Expense / Debt = 4.86% (Interest Expense 1.50b / Debt 30.9b)
Taxrate = 28.36% (4.98b / 17.6b)
NOPAT = 15.1b (EBIT 21.1b * (1 - 28.36%))
Current Ratio = 0.79 (Total Current Assets 17.1b / Total Current Liabilities 21.7b)
Debt / Equity = 1.99 (Debt 30.9b / totalStockholderEquity, last quarter 15.5b)
Debt / EBITDA = 1.12 (Net Debt 27.0b / EBITDA 24.1b)
Debt / FCF = 1.82 (Net Debt 27.0b / FCF TTM 14.8b)
Total Stockholder Equity = 18.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.23% (Net Income 11.8b / Total Assets 70.4b)
RoE = 64.23% (Net Income TTM 11.8b / Total Stockholder Equity 18.4b)
RoCE = 47.85% (EBIT 21.1b / Capital Employed (Equity 18.4b + L.T.Debt 25.7b))
RoIC = 31.87% (NOPAT 15.1b / Invested Capital 47.4b)
WACC = 5.31% (E(106b)/V(137b) * Re(5.84%) + D(30.9b)/V(137b) * Rd(4.86%) * (1-Tc(0.28)))
Discount Rate = 5.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.21 | Cagr: -6.50%
[DCF] Terminal Value 77.97% ; FCFF base≈13.7b ; Y1≈15.7b ; Y5≈23.1b
[DCF] Fair Price = 147.6 (EV 348b - Net Debt 27.0b = Equity 321b / Shares 2.17b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -19.39 | EPS CAGR: -5.38% | SUE: 0.0 | # QB: 0
Revenue Correlation: 53.42 | Revenue CAGR: 9.06% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=3.17 | Chg30d=+0.48% | Revisions=-14% | GrowthEPS=+2.8% | GrowthRev=+1.9%
EPS next Year (2027-12-31): EPS=3.35 | Chg30d=-0.56% | Revisions=-33% | GrowthEPS=+6.0% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: -33%